HS Code:
Poly(ethyl acrylate-co-methyl methacrylate-co-trimethylammonioethyl methacrylate chloride) (CAS No. 33434-24-1) is a specialized copolymer used primarily in industries such as pharmaceuticals, cosmetics, and advanced materials. Classified under HS Code 3906.90.50, which pertains to other acrylic polymers in primary forms, this product is valued for its film-forming, binding, and cationic properties. It is often utilized in controlled-release drug delivery systems, hair care products, and as a component in specialty coatings.
Total Trade Volume
Approximately $150 million USD
Data from 2022
Source
Estimated data based on UN Comtrade and industry reports
$45 million USD
30% of total trade of total trade
Increasing
$30 million USD
20% of total trade of total trade
Stable
$25 million USD
17% of total trade of total trade
Increasing
$15 million USD
10% of total trade of total trade
Stable
$10 million USD
7% of total trade of total trade
Decreasing
Average Rate
5.5% ad valorem
Highest Rate
8% (imposed by certain developing countries)
Lowest Rate
0% (under free trade agreements like EU-US TTIP provisions)
Growing demand in pharmaceutical applications
Increased use in drug delivery systems due to biocompatibility and controlled-release properties, driving market growth by 6% annually
2021-2023
Shift towards sustainable production methods
Manufacturers are adopting greener synthesis processes to meet environmental regulations, slightly increasing production costs
2022-2023
Rising competition from Asian manufacturers
Lower production costs in countries like China are challenging traditional European and American producers, leading to price pressures
2020-2023
The European Union introduced stricter guidelines for cationic polymers used in cosmetics, requiring additional safety data submissions.
March 2023
Potential delays in market entry for non-compliant products, increasing compliance costs for exporters to the EU.
A recent bilateral agreement reduced tariffs on specialty chemicals, including certain acrylic polymers, from 7% to 3%.
January 2023
Expected to boost exports from China to the US, potentially shifting market dynamics in North America.
A leading German manufacturer announced a breakthrough in using this copolymer for next-gen oral drug delivery systems.
September 2022
Likely to increase demand in the pharmaceutical sector, reinforcing Germany's position as a market leader.